Paragon Associates & Paragon Associates Ii Joint Venture Iridex Corp Transaction History
Paragon Associates & Paragon Associates Ii Joint Venture
- $42.5 Million
- Q4 2024
A detailed history of Paragon Associates & Paragon Associates Ii Joint Venture transactions in Iridex Corp stock. As of the latest transaction made, Paragon Associates & Paragon Associates Ii Joint Venture holds 1,000,000 shares of IRIX stock, worth $1.17 Million. This represents 4.0% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 1,000,000
-0.0%
Holding current value
$1.17 Million
Previous $1.75 Million
2.86%
% of portfolio
4.0%
Previous 3.24%
Shares
10 transactions
Others Institutions Holding IRIX
# of Institutions
28Shares Held
3.21MCall Options Held
0Put Options Held
4.4K-
Vanguard Group Inc Valley Forge, PA561KShares$656,4820.0% of portfolio
-
Amh Equity LTD501KShares$586,3110.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny381KShares$445,9570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA131KShares$153,4710.0% of portfolio
-
Ars Investment Partners, LLC110KShares$128,7700.02% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $18.7M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...